Elsevier scoops up scientific software outfit Ariadne

Amsterdam-based information products giant Elsevier has gobbled up Ariadne Genomics, a company that provides software allowing researchers to study molecular pathways and disease progression. With scientists facing a deluge of data from a number of publications, Rockville, MD-based Ariadne's software uses semantics technologies to tap multiple content sources for material on molecular pathways and disease progression, according to Elsevier. Ariadne, with its main product Pathway Studio, is expected to become part of the buyer's Corporate Markets unit, but financial terms of the deal, which was announced Dec. 8, weren't disclosed. Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.